The afternoon of March 14th
To “gather the innovation momentum of industry, academia and research”
Building a high-quality development system” as the theme
The 4th Shenzhen Enterprise Innovation Promotion Conference and
Shenzhen Federation of Industry 2023 Annual Meeting
Grandly held at Shenzhen Wuzhou Hotel
The conference grandly released and commended multiple awards including the 22nd Shenzhen Enterprise Innovation Record and the 2023 Bay Area Enterprise Innovation List. The strength of Beike Biotechnology is on the list, winning four honors at once——
Beike Biology
Won the title of “The 22nd Shenzhen Enterprise Innovation Record—Independent Innovation Benchmark Enterprise”
Won the “2023 Guangdong-Hong Kong-Macao Greater Bay Area Enterprise Innovation List—High-Growth Innovation List”
Dr. Hu Junyuan, founder and chairman of Beike Biotech
Selected into the “2023 Guangdong-Hong Kong-Macao Greater Bay Area Enterprise Innovation List – List of Outstanding Innovation Figures”
Selected into the “2023 Guangdong-Hong Kong-Macao Greater Bay Area Enterprise Innovation List—Persons with Outstanding Contributions to Innovation”
01. Shenzhen enterprise innovation records demonstrate the vitality of technological innovation
The “Shenzhen Enterprise Innovation Record” review and release event was founded in 2002 and has been held for 22 consecutive sessions. The 22nd “Shenzhen Enterprise Innovation Record” reviewed and released 209 projects from 157 companies, involving 28 industries such as communication equipment, software, medical equipment, pharmaceutical manufacturing, and general equipment manufacturing.
Previously, in the 22nd “Shenzhen Enterprise Innovation Record” announced, the “Key Technology Innovation and Clinical Application Research of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus Erythematosus” project submitted by Beike Biotech was successfully shortlisted for the “Shenzhen Enterprise Innovation Record” and won the “Innovation Project Award for Product Research and Development”. Only 27 of the 209 projects approved this year won the 22nd “Shenzhen Enterprise Innovation Record” Product R&D Innovation Project Award.
02, 2023 Guangdong-Hong Kong-Macao Greater Bay Area Enterprise Innovation Ranking
The 2023 Guangdong-Hong Kong-Macao Greater Bay Area Enterprise Innovation Ranking is jointly selected by the Shenzhen Federation of Industry, Guangdong Bay Area New Economic Research Institute, Shenzhen Science and Technology Association, Shenzhen Lihe Science and Technology Co., Ltd., Shenzhen Business Daily, Shenzhen Innovation Development Research Institute and other institutions. The companies selected for the “list” have strong comprehensive strength, and there are many national-level manufacturing individual champions that rank first in the country and among the top three in the world in terms of market share, as well as “specialized, special and new” little giants with specialization, refinement, distinctiveness and outstanding innovation capabilities. Overall, the selected companies all attach great importance to independent innovation and have strong core competitiveness; they have outstanding innovation achievements in strategic emerging industries; they have outstanding industry status and drive the integrated development of the industrial chain. Those selected for the “List of Outstanding Innovation Figures” are all entrepreneurs and technical leaders of enterprises who have led enterprises to achieve outstanding innovation results.
Winning multiple honors this time is a high recognition of the growth value, scientific research strength and innovation achievements of Beike Biotech. It is also a full affirmation of its strategy of “leading the high-quality development of enterprises through innovation”. This is an affirmation, and it is also a responsibility to spur the company to move forward. Innovation is a powerful driving force for high-quality development of enterprises. In the future, Beike Biotech will continue to work intensively in the field of cells, insist on promoting the transformation of innovative scientific and technological achievements as an important driving force for corporate development, actively explore innovative application fields in life sciences, provide customers with more valuable, cutting-edge, and cutting-edge products, and promote the high-quality development of the domestic life sciences industry.